Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             285 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2011
 20 S1 p. S87-S93
7 p.
 artikel
2 Award Lecture Evolution of long-term adjuvant anti-hormone therapy: Consequences and opportunities Jordan, V.C.
 2011
 20 S1 p. S1-
1 p.
 artikel
3 Editorial Board 2011
 20 S1 p. iii-
1 p.
 artikel
4 P325 A Belgian observational study to evaluate fulvestrant use in current clinical practice Neven, P.
 2011
 20 S1 p. S79-
1 p.
 artikel
5 P315 Acceptance and adherence with oral endocrine therapy in women with metastatic breast cancer: ExaCampania group study Addeo, R.
 2011
 20 S1 p. S76-S77
2 p.
 artikel
6 P242 Accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients Takahashi, M.
 2011
 20 S1 p. S57-S58
2 p.
 artikel
7 P285 A clinical comparison of letrozole or anastrozole for the treatment of hormone-positive breast cancer using indirect statistical techniques Dranitsaris, G.
 2011
 20 S1 p. S69-
1 p.
 artikel
8 P157 A clinico-pathological analysis of breast cancer patients with a family history Nakagawa, A.
 2011
 20 S1 p. S32-
1 p.
 artikel
9 P215A Cost–benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore de Lima Lopes, G.
 2011
 20 S1 p. S48-
1 p.
 artikel
10 P301 Addition of pertuzumab (P) to trastuzumab (H)-based neoadjuvant chemotherapy significantly improves pathological complete response in women with HER2-positive early breast cancer: Result of a randomised phase II study (NEOSPHERE) Gianni, L.
 2011
 20 S1 p. S73-
1 p.
 artikel
11 P123 Additive antitumor effect of plant polyphenols and a synthetic inhibitors of polyamines biosynthesis Samoylenko, O.
 2011
 20 S1 p. S22-S23
2 p.
 artikel
12 P292 Adjuvant endocrine therapy in stage I breast cancer in a regional oncology practice after the introduction of aromatase inhibitors as a universal health benefit in Israel Tokar, M.
 2011
 20 S1 p. S71-
1 p.
 artikel
13 P274 Adriamycin & cyclophosphamide (AC) followed by docetaxel (D) versus AC followed by paclitaxel (P) in operable node positive breast cancer Abdel-Halim, I.
 2011
 20 S1 p. S65-
1 p.
 artikel
14 P124 Alpha-type 1 polarized dendritic cells loaded with apoptotic allogeneic breast cancer cells can induce potent cytotoxic T lymphocytes against breast cancer Park, M.H.
 2011
 20 S1 p. S23-
1 p.
 artikel
15 P162 A new mammographic classification as a potential predictor of breast disorders for Asian women Tamaki, K.
 2011
 20 S1 p. S33-
1 p.
 artikel
16 P125 Application of biomarkers to sentinel lymph node biopsy for the management of breast cancer Chow, L.W.-C.
 2011
 20 S1 p. S23-
1 p.
 artikel
17 P146 Asian/Chinese breast cancer in the elderly is associated with a lower rate of estrogen-receptor positive expression compared to their Western/Austrian counterparts Tea, M.-K.M.
 2011
 20 S1 p. S29-
1 p.
 artikel
18 P320 Association of triple-negative breast cancer with extracapsular extension of axillary lymph node metastasis Maksimovic, S.
 2011
 20 S1 p. S78-
1 p.
 artikel
19 P279 A survey of Taxotere–cyclophosphamide–Herceptin (TCYCH) chemotherapy use and safety profile in HER-2 positive breast cancer patients in Australia Yeung, Y.H.
 2011
 20 S1 p. S67-
1 p.
 artikel
20 P257 A 7-year experience of targeted intra-operative radiation therapy (TARGIT) using PRS400 photon radiosurgery system (intrabeam) for breast cancer Wydmański, J.
 2011
 20 S1 p. S61-
1 p.
 artikel
21 P284 Baseline assessment of patient-reported outcomes (PROs) for breast cancer patients after 5-years of endocrine treatment in a randomized clinical trial: NSAS-BC 05 Yagata, H.
 2011
 20 S1 p. S68-
1 p.
 artikel
22 P347 Benefit of denosumab therapy in patients with bone metastases from breast cancer: A number-needed-to-treat (NNT) analysis Martin, M.
 2011
 20 S1 p. S85-
1 p.
 artikel
23 P215B Evaluation of the cost-effectiveness of Oncotype-DX® multigene assay in Hungary Madaras, B.
 2011
 20 S1 p. S48-S49
2 p.
 artikel
24 P148 Breast cancer among the young and elderly populations in Japan: Which differences can be seen? Tomiyama, S.
 2011
 20 S1 p. S29-S30
2 p.
 artikel
25 P156 Breast cancer in elderly patients Boroday, N.
 2011
 20 S1 p. S32-
1 p.
 artikel
26 P106 Breast cancer tissue tryptase expression as a new possible antiangiogenic target Ammendola, M.
 2011
 20 S1 p. S18-
1 p.
 artikel
27 P324 Breast cancer treatment: A single institution audit with 20-year follow up Rastogi, N.
 2011
 20 S1 p. S79-
1 p.
 artikel
28 P164 Breast self examination practice and its efficient factors among women in Ardabil Akhavan Akbari, P.
 2011
 20 S1 p. S34-
1 p.
 artikel
29 P238 Breast sentinel lymph node analysis intraoperative with OSNA (One step Nucleic Acid Amplification) to avoid second surgery for axillary lymph node dissection Godey, F.
 2011
 20 S1 p. S56-S57
2 p.
 artikel
30 P170 Breast-specific gamma imaging with 99mTc-Sestamibi in the diagnosis of breast cancer for Korean women Lee, A.
 2011
 20 S1 p. S35-S36
2 p.
 artikel
31 P307 Capecitabine (C) for triple-negative early breast cance (TNBC): Review of available clinical data Steger, G.G.
 2011
 20 S1 p. S75-
1 p.
 artikel
32 P343 CARIATIDE trial: the impact of educational materials (EM) on patients' compliance with adjuvant aromatase inhibitor (AI) therapy and quality of life (QoL) Markopoulos, C.
 2011
 20 S1 p. S83-S84
2 p.
 artikel
33 P215C Impact on hospital costs of the ROLL technique (radioguided occult lesion localization) Marta, B.
 2011
 20 S1 p. S49-
1 p.
 artikel
34 P322 Clinical and economic impact of skeletal-related events in breast cancer patients with bone metastases Carter, J.
 2011
 20 S1 p. S78-
1 p.
 artikel
35 P110 Clinical feature of breast ductal carcinoma in situ arising in sclerosing adenosis Yoshida, A.
 2011
 20 S1 p. S19-
1 p.
 artikel
36 P252 Clinical implication of the internal mammary lymph node detected by lymphoscintigraphy Bae, S.Y.
 2011
 20 S1 p. S60-
1 p.
 artikel
37 P118 Clinical usefulness of liquid-based cytology in hormone receptor analysis for fine needle aspiration specimens of breast cancer patients Aogi, K.
 2011
 20 S1 p. S21-
1 p.
 artikel
38 P248 Clinicopathological characteristics of the breast cancer patients with micrometastatic sentinel lymph nodes Nishiya, S.
 2011
 20 S1 p. S59-
1 p.
 artikel
39 P159 Clinico-pathological features of surgically-treated bilateral breast cancers Tokuda, E.
 2011
 20 S1 p. S32-S33
2 p.
 artikel
40 P150 Coffee consumption modifies risk of estrogen-receptor negative breast cancer Li, J.
 2011
 20 S1 p. S30-
1 p.
 artikel
41 P246 Comparison of three different methods for detecting sentinel lymph node in breast cancer Colakoglu, K.
 2011
 20 S1 p. S58-S59
2 p.
 artikel
42 P117 Concordance between immunohistochemistry and fluorescence in situ hybridization for assessment of the HER2 Cho, S.H.
 2011
 20 S1 p. S21-
1 p.
 artikel
43 P222 Contralateral prophylactic nipple sparing mastectomy for unilateral breast cancer Grube, B.
 2011
 20 S1 p. S52-S53
2 p.
 artikel
44 P265 Cosmetic outcome one, two, three and four years after intra-operative radiotherapy compared with external beam radiotherapy for early breast cancer: an objective assessment of patients from a randomised controlled trial Keshtgar, M.
 2011
 20 S1 p. S63-
1 p.
 artikel
45 P262 Cost-effectiveness of intraoperative radiation therapy for breast conservation Alvarado, M.D.
 2011
 20 S1 p. S62-S63
2 p.
 artikel
46 P188 Could the lack of expression of steroid receptors and HER2 discriminate a subgroup of triple negative breast cancer patients with poorer prognosis? Milovic-Kovacevic, M.M.
 2011
 20 S1 p. S40-S41
2 p.
 artikel
47 P192 CUB-domain containing protein (CDCP1)-mediated anchorage free survival and migratory properties in breast cancer cell lines are not affected by tyrosine kinase inhibitor lapatinib Seidel, J.
 2011
 20 S1 p. S42-
1 p.
 artikel
48 P296 Current patterns and long-time trends in the adjuvant systemic therapy of breast cancer in Grodno region (Belarus) Kazakevich, D.
 2011
 20 S1 p. S72-
1 p.
 artikel
49 P333 Darbepoetin alfa effectiveness in breast cancer patients – Data from the CHOICE study Van Belle, S.
 2011
 20 S1 p. S81-
1 p.
 artikel
50 P115 Decreased Hsp90 expression in the continuum of breast lobular lesions Zagouri, F.
 2011
 20 S1 p. S20-S21
2 p.
 artikel
51 P193 Demographic features and prognostic profiles of Chinese breast cancer patients with ≥4 involved axillary lymph nodes Yin, W.
 2011
 20 S1 p. S42-
1 p.
 artikel
52 P337 Depersonalization disorder and breast cancer patients' psychotherapy Manrique, M.
 2011
 20 S1 p. S82-
1 p.
 artikel
53 P233 Descriptive results of surgical treatment for breast cancer: A 30-year experience in the northeast of China Li, S.
 2011
 20 S1 p. S55-
1 p.
 artikel
54 P154 Diagnosis of breast cancer during pregnancy: A five year experience Dimitrakakis, C.
 2011
 20 S1 p. S31-
1 p.
 artikel
55 P184 Differential pathologic response from primary systemic chemotherapy across breast cancer intrinsic subtypes Jinno, H.
 2011
 20 S1 p. S39-S40
2 p.
 artikel
56 P302 Discordance in hormone receptor and HER2 status in breast cancer during neoadjuvant chemotherapy Maeda, S.
 2011
 20 S1 p. S73-
1 p.
 artikel
57 P210 Discordance of prognostic risk between histopathology and gene signature in Japanese early breast cancer Saito, M.
 2011
 20 S1 p. S47-
1 p.
 artikel
58 P251 3D navigated sentinel lymph node biopsy in 29 breast cancer patients with use of freehand SPECT for intraoperative navigation and quality assurance Schnelzer, A.
 2011
 20 S1 p. S60-
1 p.
 artikel
59 P304 Docetaxel, carboplatin and weekly trastuzumab are active as neoadjuvant therapy in operable HER2-positive breast cancer Kolberg, H.-C.
 2011
 20 S1 p. S74-
1 p.
 artikel
60 P318 Does primary tumor excision affect survival in metastatic breast cancer? Vohra, L.M.
 2011
 20 S1 p. S77-
1 p.
 artikel
61 P267 Does the steroid receptor (SR) status influence the response to preoperative radiotherapy in locally advanced breast cancer patients? Mladenovic, J.
 2011
 20 S1 p. S64-
1 p.
 artikel
62 P195 Do medullar histology and type of adjuvant chemotherapy influence the short term outcome of triple negative early breast cancer patients? Susnjar, S.
 2011
 20 S1 p. S42-
1 p.
 artikel
63 P140 Do medullary breast cancer patients have better prognosis compared to patients with breast cancer of other tumor types? Posarac, V.
 2011
 20 S1 p. S27-
1 p.
 artikel
64 P215D Sensitizing primary healthcare workers towards psychosocial issues of breast-cancer patients: NGO's policy in developing nations Shankpal, P.
 2011
 20 S1 p. S49-
1 p.
 artikel
65 P215E Cultural economical and social perceptions of breast cancer patients education: Status in developing nations Shankpal, P.
 2011
 20 S1 p. S49-S50
2 p.
 artikel
66 P288 Effects of exemestane or tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis Hadji, P.
 2011
 20 S1 p. S70-
1 p.
 artikel
67 P300 Efficacy and safety of docetaxel combined with oxaliplatin as neoadjuvant chemotherapy regimen for triple negative local advanced breast cancer patients Fei, F.
 2011
 20 S1 p. S72-S73
2 p.
 artikel
68 P303 Efficacy and safety of neoadjuvant weekly paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide: A multicenter study Anan, K.
 2011
 20 S1 p. S73-S74
2 p.
 artikel
69 P331 Efficacy and safety of scalp cooling to prevent chemotherapy (CTX) induced alopecia: A review of available data Rugo, H.S.
 2011
 20 S1 p. S80-
1 p.
 artikel
70 P329 Efficacy of scalp cooling not dependent on hair type Saltmarsh, K.
 2011
 20 S1 p. S80-
1 p.
 artikel
71 P129 Efforts to standardise Ki-67 counting in breast cancer. A pilot study of the Swiss Working Group of Gyneco- and Breast Pathologists Varga, Z.
 2011
 20 S1 p. S24-
1 p.
 artikel
72 P144 Epidemiological characteristics of breast cancer in Chinese population aged 25–70 years old Yu, G.Z.
 2011
 20 S1 p. S28-
1 p.
 artikel
73 P101 Estrogen receptors, progesterone receptors, and nuclear size in Libyan female breast cancer: Correlation with clinical features and survival Boder, J.M.
 2011
 20 S1 p. S17-
1 p.
 artikel
74 P209 Evaluating conventional pathological factors against the standardized 21-gene signature for hormone receptor positive breast cancer patients Onoda, T.
 2011
 20 S1 p. S46-S47
2 p.
 artikel
75 P291 Evaluating the impact of educational material on anastrozole treatment adherence – the baseline results of the ARTEMIS study Nogaret, J.-M.
 2011
 20 S1 p. S70-S71
2 p.
 artikel
76 P330 Evaluation of DigniCap™ system for the prevention of chemotherapy-induced hair loss in breast cancer patient Kato, M.
 2011
 20 S1 p. S80-
1 p.
 artikel
77 P149 Evaluation of family histories and analysis of BRCA1 founder mutations in a population-based series of breast and ovarian cancer cases in Latvia Plakhins, G.
 2011
 20 S1 p. S30-
1 p.
 artikel
78 P239 Examination about the adaptation of sentinel lymph node biopsy after neoadjuvant chemotherapy using 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in breast cancer Shigekawa, T.
 2011
 20 S1 p. S57-
1 p.
 artikel
79 P127 Expression of 11β-hydroxysteroid dehydrogenase type 1 in breast cancer and adjacent non-malignant tissue – a correlation to clinical factors Lu, L.
 2011
 20 S1 p. S24-
1 p.
 artikel
80 P181 Factors influencing prognosis in node-negative early breast cancer (p)T1N0M0 Semiglazov, V.F.
 2011
 20 S1 p. S39-
1 p.
 artikel
81 P215F Breast cancer in the 3rd decade Korean young ladies Minsun, K.
 2011
 20 S1 p. S50-
1 p.
 artikel
82 P207 Feasibility of Mammaprint risk assessment using vacuum-assisted breast biopsy (Mammotome) in early breast cancer Osaki, A.
 2011
 20 S1 p. S46-
1 p.
 artikel
83 P278 Feasibility study of adjuvant fluorouracil/epirubicin/cyclophosphamide (FEC 100) followed by triweekly docetaxel (D) plus trastuzumab (H) in HER2/neu positive early breast cancer Tanaka, M.
 2011
 20 S1 p. S66-S67
2 p.
 artikel
84 P336 Fertility concerns and treatment decisions in young breast cancer patients Jain, M.
 2011
 20 S1 p. S82-
1 p.
 artikel
85 P243 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) is useful for selecting optimal patients suited for sentinel lymph node biopsy after primary systemic chemotherapy in breast cancer Shigekawa, T.
 2011
 20 S1 p. S58-
1 p.
 artikel
86 P105 FGFR2 and TP53 work together in breast cancer Denisov, E.V.
 2011
 20 S1 p. S18-
1 p.
 artikel
87 P112 FGF-8 stimulates breast cancer cell mitosis by regulating BMP and ER actions Masuda, H.
 2011
 20 S1 p. S20-
1 p.
 artikel
88 P268 Frequency and anatomical characteristics of involved regional lymph nodes in recurrent and advanced breast cancer Chen, J.-Y.
 2011
 20 S1 p. S64-
1 p.
 artikel
89 P215G A new organic product – 100% silk bra, prevention for breast cancer? Hu, Z.
 2011
 20 S1 p. S50-
1 p.
 artikel
90 P185 GATA-3 as a new prognostic marker in breast cancer Kim, L.S.
 2011
 20 S1 p. S40-
1 p.
 artikel
91 P206 German multicentre decision impact study of Oncotype DX recurrence score (RS) on adjuvant treatment in estrogen receptor positive (ER+) node negative (N0) and node positive (N+) early breast cancer Blohmer, J.-U.
 2011
 20 S1 p. S46-
1 p.
 artikel
92 P202 Gross financial evaluation of the application of the 21-gene assay Oncotype DX for adjuvant chemotherapy decision-making in estrogen receptor-positive node negative breast cancer in Greece Liaropoulos, L.
 2011
 20 S1 p. S44-
1 p.
 artikel
93 P120 Guggulsterone isomers (cis or trans) differently control TPA-induced MMP-9 expressions of MCF-7 cells Youn, H.J.
 2011
 20 S1 p. S22-
1 p.
 artikel
94 P169 Health-related quality of life after stereotactic vacuum assisted breast biopsy utilizing radiofrequency: The Greek trial experience Matiatou, M.A.
 2011
 20 S1 p. S35-
1 p.
 artikel
95 P153 HER2 positive breast cancer among BRCA1/2 mutation carriers Burgos-Dago-Oc, J.A.
 2011
 20 S1 p. S31-
1 p.
 artikel
96 P226 High resolution ultrasound guided location of non palpable breast lesions is safe and can significantly reduce hook-wire guided surgery Nia, A. Huschmand
 2011
 20 S1 p. S53-S54
2 p.
 artikel
97 P211 High SUV max of 18f FDG-PET/CT is significantly associated with poor outcome in operable breast cancer Ohara, M.
 2011
 20 S1 p. S47-
1 p.
 artikel
98 P212 High VEGF-C/VEGF-D mRNA expression ratio in breast cancer may correlate with lymph node metastasis and recurrence Koyama, Y.
 2011
 20 S1 p. S47-
1 p.
 artikel
99 P179 HOXB9 expression is a significant prognostic factor for clinical outcomes in breast cancer Hayashida, T.
 2011
 20 S1 p. S38-
1 p.
 artikel
100 P131 Identification and characterization of proteomic changes associated to tamoxifen-resistance in breast cancer cells Sanchez, B.C.
 2011
 20 S1 p. S25-
1 p.
 artikel
101 P280 Identification of factors associated with the participation in an adjuvant treatment clinical study for patients with breast cancer Sala, R.
 2011
 20 S1 p. S67-
1 p.
 artikel
102 P109 Idiopathic granulomatous mastitis; a case series Lee, J.
 2011
 20 S1 p. S19-
1 p.
 artikel
103 P326 Immunologic and clinical effects of personalized selection of peptide vaccines in patients with refractory breast cancer Toh, U.
 2011
 20 S1 p. S79-
1 p.
 artikel
104 P260 Impact of adjuvant radiation therapy photon energy on quality of life after breast conservation therapy: Linear accelerator versus the Cobalt machine Munshi, A.
 2011
 20 S1 p. S62-
1 p.
 artikel
105 P200 Impact of the 21-gene recurrence score assay on treatment decision in early breast cancer (EBC) patients with favourable prognostic factors Markopoulos, C.
 2011
 20 S1 p. S44-
1 p.
 artikel
106 P290 Influence of letrozole on bone health in women with breast cancer – first results on quantitative ultrasonometry (QUS) at the os calcaneus and the phalanges Hadji, P.
 2011
 20 S1 p. S70-
1 p.
 artikel
107 P172 Influence of preoperative MRI in surgical management of breast carcinoma Sánchez, S.A.
 2011
 20 S1 p. S36-
1 p.
 artikel
108 P203 Inter-institutional comparison of impact of Mammaprint on the routine treatment decision-making process in early breast cancer patient populations from three European hospitals Cusumano, G.
 2011
 20 S1 p. S45-
1 p.
 artikel
109 P247 Intraoperative assessment of sentinel node in breast cancer performing one step nucleic acid amplification (OSNA) assay on the whole lymph node Sapino, A.
 2011
 20 S1 p. S59-
1 p.
 artikel
110 P244 Intra-operative detection of sentinel lymph node metastasis in breast cancer by OSNA (one step nucleic acid amplification) Görgens, D.R.
 2011
 20 S1 p. S58-
1 p.
 artikel
111 P264 Intraoperative radiotherapy in early breast cancer – a single institution experience Steiner, M.
 2011
 20 S1 p. S63-
1 p.
 artikel
112 P261 Intraoperative radiotherapy (IORT) with electrons during breast conservative surgery in early stage breast cancer: Review of our first 85 cases philippson, C.
 2011
 20 S1 p. S62-
1 p.
 artikel
113 P283 Is hormone therapy alone efficacious as postoperative adjuvant therapy in Japanese Stage I, HR+/HER2+ breast cancer patients? Ogiya, A.
 2011
 20 S1 p. S68-
1 p.
 artikel
114 P299 Is neoadjuvant chemotherapy in breast cancer increasing? Sancho Perez, B.
 2011
 20 S1 p. S72-
1 p.
 artikel
115 P108 Isolation of a 320 kDa protein from the eggs of Onchidium (sea slug) that exhibits anticancer activity against breast cancer cell line (T47D) Khodabandeh, S.
 2011
 20 S1 p. S18-S19
2 p.
 artikel
116 P306 Kinetic targeting: A new approach to reduce toxicities during nanoparticle (liposomal doxorubicin) based chemotherapy in early breast cancer (CARL Trial) Schmah, O.
 2011
 20 S1 p. S74-
1 p.
 artikel
117 P176 Ki67 proliferative index as a biomarker in discriminating luminal A and B breast cancer: Good correlation with CS-IHC4 and Adjuvant! Online Park, Y.H.
 2011
 20 S1 p. S37-
1 p.
 artikel
118 P213 Lack of membranous Ezrin expression in breast cancer cells predicts shorter overall survival Halon, A.
 2011
 20 S1 p. S48-
1 p.
 artikel
119 P229 Local recurrence risk of breast conserving surgery after neoadjuvant chemotherapy Ohtani, S.
 2011
 20 S1 p. S54-
1 p.
 artikel
120 P266 Locoregional recurrence analysis in young women (≥5 y) receiving mastectomy with operable breast cancer Tang, L.-C.
 2011
 20 S1 p. S63-S64
2 p.
 artikel
121 P240 Long-term follow-up results of sentinel lymph node biopsy using periareolar injection in breast cancer patients Cho, S.H.
 2011
 20 S1 p. S57-
1 p.
 artikel
122 P221 Long-term results of breast conserving surgery with respect to both prevention of local recurrence and cosmetic appearance Iwamoto, M.
 2011
 20 S1 p. S52-
1 p.
 artikel
123 P344 Long-term zoledronic acid-mediated suppression of bone resorption in patients receiving an aromatase inhibitor Lipton, A.
 2011
 20 S1 p. S84-
1 p.
 artikel
124 P191 Macrocytosis predicts response to metronomic chemotherapy with capecitabine and cyclophosphamide in combination with bevacizumab Dellapasqua, S.
 2011
 20 S1 p. S41-S42
2 p.
 artikel
125 P295 Management of breast cancer subtypes: Are we headed in the right direction? Zurawska, U.
 2011
 20 S1 p. S72-
1 p.
 artikel
126 P165 Management of non palpable breast lesions with stereotactic vacuum assisted core needle biopsies (mammotome). Initial experience at 12 de Octubre Hospital (Madrid) Gallego Alvarez, M.
 2011
 20 S1 p. S34-
1 p.
 artikel
127 P335 Menopausal symptoms and menstrual changes in breast cancer patients treated with GnRH analogue goserelin Ku, B.K.
 2011
 20 S1 p. S81-
1 p.
 artikel
128 P201 Meta-analysis of the decision impact of the 21-gene breast cancer Recurrence Score® in clinical practice Hornberger, J.C.
 2011
 20 S1 p. S44-
1 p.
 artikel
129 P152 Metabolic syndrome: Breast cancer risk indicator in postmenopausal women Capasso, I.
 2011
 20 S1 p. S30-S31
2 p.
 artikel
130 P321 Metastatic triple-negative breast cancer: A population based study Ess, S.
 2011
 20 S1 p. S78-
1 p.
 artikel
131 P204 Microarray based determination of ER, PR and HER2 receptor status compared to local ICH/FISH assessment in 641 patients Cusumano, G.
 2011
 20 S1 p. S45-
1 p.
 artikel
132 P103 miRNA network deregulation in breast carcinogenesis Halytskiy, V.
 2011
 20 S1 p. S17-
1 p.
 artikel
133 P190 Molecular breast cancer subtypes: relationship with clinicopathological characteristics, efficacy of neoadjuvant chemotherapy and survival Babyshkina, N.
 2011
 20 S1 p. S41-
1 p.
 artikel
134 P180 Molecular types, uPA/PAI-1, clinical and pathological features in node-negative breast cancer: Distribution within the clinical trial NNBC 3-Europe compared to a single-institution cohort Kantelhardt, E.J.
 2011
 20 S1 p. S38-
1 p.
 artikel
135 P126 Mucinous breast cancer: Morphological and immunohistochemical characterisation Abolins, A.
 2011
 20 S1 p. S23-
1 p.
 artikel
136 P141 Mucinous carcinoma of the breast Bae, S.Y.
 2011
 20 S1 p. S27-
1 p.
 artikel
137 P314 Multimodality therapy in locally advanced breast cancer – prediction of outcome by clinical and pathological features Nowicka, E.
 2011
 20 S1 p. S76-
1 p.
 artikel
138 P245 National survey of DCIS treatment in Spanish hospitals Zapardiel, I.
 2011
 20 S1 p. S58-
1 p.
 artikel
139 P305 Neoadjuvant chemotherapy should also be considered for lobular breast cancer Fitzal, F.
 2011
 20 S1 p. S74-
1 p.
 artikel
140 P309 Neoadjuvant use of endocrine therapy in elderly patients with estrogen receptor-positive breast cancer: Series of a general hospital Muñnoz-Sanchez, M.M.
 2011
 20 S1 p. S75-
1 p.
 artikel
141 P310 Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy Keam, B.
 2011
 20 S1 p. S76-
1 p.
 artikel
142 P273 Non-pegylated liposomal doxorubicin in combination with cyclophosphamide and docetaxel as adjuvant therapy for women with high-risk breast cancer. Safety, quality of life, and efficacy analysis of TMC protocol Addeo, R.
 2011
 20 S1 p. S65-
1 p.
 artikel
143 P218 Oncological safety and satisfaction in early-stage breast cancer patients treated with immediate autologous breast reconstruction after skin-sparing mastectomy in a Chinese population Chen, J.-J.
 2011
 20 S1 p. S51-
1 p.
 artikel
144 P223 Oncologic outcome of areola-sparing mastectomy with immediate reconstruction using free flap techniques compared with conventional skin-sparing mastectomy Net, N.
 2011
 20 S1 p. S53-
1 p.
 artikel
145 P216 Oncologic safety and feasibility of endoscopy-assisted breast surgery in early breast cancer: 5 years follow up results Kim, J.H.
 2011
 20 S1 p. S51-
1 p.
 artikel
146 P217 Oncoplastic surgery in surgical treatment of breast cancer: is the initiation of adjuvant treatment delayed? Dogan, L.
 2011
 20 S1 p. S51-
1 p.
 artikel
147 P197 Oncotype Dx; St. Gallen risk group and Adjuvant!online nomogram as prognostic predictor for lymph nodes positive breast cancer patients Leitzin, L.
 2011
 20 S1 p. S43-
1 p.
 artikel
148 P308 Optimal duration of neoadjuvant exemestane treatment in elderly women with estrogen receptor-positive/HER2-negative breast cancer Takei, H.
 2011
 20 S1 p. S75-
1 p.
 artikel
149 P224 Optimizing breast conserving surgery by ex vivo ultrasound and radiological examination of breast cancer tissue Nia, A. Huschmand
 2011
 20 S1 p. S53-
1 p.
 artikel
150 P174 Our initial experience of digital breast tomosynthesis (DBT) in terms of radiation safety and reporting Khawaja, S.
 2011
 20 S1 p. S37-
1 p.
 artikel
151 P143 Over 28,000 cases in the European Institute of Oncology breast cancer database: a simple organization for complex data Santillo, B.
 2011
 20 S1 p. S28-
1 p.
 artikel
152 P122 Overexpression of ezrin is related to malignancy of breast tumors Gschwantler-Kaulich, D.
 2011
 20 S1 p. S22-
1 p.
 artikel
153 P104 Overexpression of MMP-9 and HIF-1α in breast cancer cells under hypoxic conditions Jaeyoung, C.
 2011
 20 S1 p. S17-S18
2 p.
 artikel
154 P167 Pain in stereotactic vacuum assisted breast biopsy with the use of radiofrequency Kalles, V.
 2011
 20 S1 p. S35-
1 p.
 artikel
155 P334 Patient seminar for women operated for breast cancer Frydensberg, M.
 2011
 20 S1 p. S81-
1 p.
 artikel
156 P237 Patterns of nodal enhancement on MR imaging with SPIO in patients with breast cancer demonstrating positive sentinel nodes Motomura, K.
 2011
 20 S1 p. S56-
1 p.
 artikel
157 P319 Phase II study of high-dose toremifene as first line treatment of metastatic breast cancer in patients with adjuvant aromatase inhibitor-resistance Sawaki, M.
 2011
 20 S1 p. S77-S78
2 p.
 artikel
158 P316 Phase II study of weekly albumin-bound paclitaxel combined with cisplatin in patients with advanced breast cancer Hu, X.
 2011
 20 S1 p. S77-
1 p.
 artikel
159 P231 Phase II study on radiofrequency ablation for early breast cancer patients Moto, S.
 2011
 20 S1 p. S54-S55
2 p.
 artikel
160 P275 Platinum compounds (PLcs) added to standard adjuvant or neoadjuvant regimen of doxorubicin plus cyclophosphamide (AC), followed by weekly paclitaxel (wP) in triple negative (TN), HER 2-neu positive (HER 2+) or locally advanced breast cancer (LABC) Vassilaki, M.
 2011
 20 S1 p. S66-
1 p.
 artikel
161 P134 Pomolic acid enhances the growth inhibition and apoptosis in human breast cancer cell Lee, J.S.
 2011
 20 S1 p. S26-
1 p.
 artikel
162 P332 Population-based incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: A prospective study Rayson, D.
 2011
 20 S1 p. S80-S81
2 p.
 artikel
163 P163 Preliminary study of Chinese high-risk population screening model for breast cancer Zhang, Q.
 2011
 20 S1 p. S33-S34
2 p.
 artikel
164 P286 Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment Gnant, M.
 2011
 20 S1 p. S69-
1 p.
 artikel
165 P182 Presence of an in-situ component predicts reduced tumor aggressiveness in luminal subtype of invasive breast cancer Wong, H.
 2011
 20 S1 p. S39-
1 p.
 artikel
166 P142 Primary non-Hodgkin's lymphomas of the breast: A single institution study Giardina, G.P.
 2011
 20 S1 p. S28-
1 p.
 artikel
167 P187 Prognostic and predictive significance of multidrug resistance-associated protein 2 (MRP2) expression and its subcellular localization in breast cancer Matkowski, R.
 2011
 20 S1 p. S40-
1 p.
 artikel
168 P214 Prognostic factors for response to neoadjuvant chemotherapy in patients with breast cancer Kang, S.Y.
 2011
 20 S1 p. S48-
1 p.
 artikel
169 P138 Prognostic factors of triple-negative breast cancer Rojratsirikul, C.
 2011
 20 S1 p. S26-S27
2 p.
 artikel
170 P183 Prognostic impact of discordance of biological markers between primary and metastatic breast cancer tissue from autopsy Nogami, T.
 2011
 20 S1 p. S39-
1 p.
 artikel
171 P208 Prognostic implications of miR-21 and miR-210 overexpression in invasive ductal carcinomas of the breast Lee, J.A.
 2011
 20 S1 p. S46-
1 p.
 artikel
172 P186 Prognostic role of VEGFR1–3 immunoreactivity in breast cancer patients Gisterek, I.J.
 2011
 20 S1 p. S40-
1 p.
 artikel
173 P178 Prospective comparison of uPA/PAI-1, Ki-67 based molecular classification, Recurrence Score and clinical–pathological characteristics in hormone-receptor (HR) positive primary breast cancer: Pilot phase of the randomized WSG PlanB trial Liedtke, C.
 2011
 20 S1 p. S38-
1 p.
 artikel
174 P289 Prospective study to assess fluid accumulation and tendosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome – 2 year follow-up data Lintermans, A.
 2011
 20 S1 p. S70-
1 p.
 artikel
175 P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer Albanell, J.
 2011
 20 S1 p. S43-
1 p.
 artikel
176 P341 Psychosocial impacts of breast cancer and its treatment on Indian patients Chander, S.
 2011
 20 S1 p. S83-
1 p.
 artikel
177 P317 Pulmonary resection for metastatic breast cancer may result in a survival benefit in selected cases Higaki, K.
 2011
 20 S1 p. S77-
1 p.
 artikel
178 P235 Quality of life and satisfaction of patients diagnosed and treated for breast cancer Sanz, M.
 2011
 20 S1 p. S55-S56
2 p.
 artikel
179 P340 Quality of life of breast cancer patients undergoing radiotherapy Bulotiene, G.
 2011
 20 S1 p. S83-
1 p.
 artikel
180 P258 Radiation safety of intra-operative breast radiotherapy with INTRABEAM – experience from the TARGIT randomised controlled trial Eaton, D.J.
 2011
 20 S1 p. S61-
1 p.
 artikel
181 P263 Radiologic evaluation of breast after intraoperative radiotherapy (IORT) in early breast cancer patients Sikorsky, N.
 2011
 20 S1 p. S63-
1 p.
 artikel
182 P272 Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC), followed by docetaxel (T) with or without capecitabine (X), in high-risk early breast cancer (EBC): efficacy results O'Shaughnessy, J.
 2011
 20 S1 p. S65-
1 p.
 artikel
183 P281 Randomized phase II trial of adjuvant vinorelbine and epirubicin versus adriamycin and cyclophosphamide in node negative breast cancer [AViEN trial] Kim, K.S.
 2011
 20 S1 p. S67-S68
2 p.
 artikel
184 P346 Real world considerations for bisphosphonate (BP) therapy in early breast cancer (EBC) Aapro, M.
 2011
 20 S1 p. S84-S85
2 p.
 artikel
185 P161 Relationship of breast size and cancer lymphogenous dissemination Zautashvili, Z.
 2011
 20 S1 p. S33-
1 p.
 artikel
186 P338 Relevance of the presence of psychooncologist: Analysis of a pilot study in the breast tumors committee in a general hospital Muñnoz-Sanchez, M.D.M.
 2011
 20 S1 p. S82-
1 p.
 artikel
187 P196 Results from a prospective clinical study on the impact of Oncotype DX on adjuvant treatment decision and risk classification by Nottingham prognostic index (NPI) and recurrence score (RS) Holt, S.D.H.
 2011
 20 S1 p. S43-
1 p.
 artikel
188 P225 Results of combined treatment of breast oncoplastic operations Ostapenko, V.
 2011
 20 S1 p. S53-
1 p.
 artikel
189 P160 Review of breast cancer diagnosed in a cohort of BRCA1/2 carriers Clara, A.
 2011
 20 S1 p. S33-
1 p.
 artikel
190 P145 Risk factors related to female breast cancer in regions of China: A paired case–control study based on population Zhang, Q.
 2011
 20 S1 p. S28-S29
2 p.
 artikel
191 P133 Role of paracrine influence of T-lymphocytes in the regulation of breast carcinogenesis on model of multicellular tumor spheroids Perepelytsina, O.
 2011
 20 S1 p. S25-
1 p.
 artikel
192 P219 Safety of fat grafting in secondary breast reconstruction after cancer Ahmed, Y.S.
 2011
 20 S1 p. S52-
1 p.
 artikel
193 P323 Second interim analysis of dose density with zoledronic acid treatment in metastatic breast cancer patients. ZARAS study Rodríguez-Lescure, A.
 2011
 20 S1 p. S78-S79
2 p.
 artikel
194 P119 Semi-quantitative immunohistofluorescence method for evaluating CD44+/CD24− tumor cells in breast tumor tissues Kai, M.
 2011
 20 S1 p. S21-S22
2 p.
 artikel
195 P241 Sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients Kinoshita, T.
 2011
 20 S1 p. S57-
1 p.
 artikel
196 P250 Sentinel lymph node biopsy in large node negative breast cancers: results of a validation study using low-cost blue dye & 99mTc-antimony colloid Agarwal, G.
 2011
 20 S1 p. S60-
1 p.
 artikel
197 P116 Serum levels of Hsp90 in the continuum of breast ductal and lobular lesions Zagouri, F.
 2011
 20 S1 p. S21-
1 p.
 artikel
198 P130 Significance of simultaneous estrogen receptor 1 gene and topoisomerase IIA imbalances in breast carcinoma based on tissue microarrays analysis Salemis, N.S.
 2011
 20 S1 p. S24-S25
2 p.
 artikel
199 P277 Simultaneous study of docetaxel based anthracycline free adjuvant treatment evaluation, as well as life style intervention strategies: The German SUCCESS C trial Salmen, J.
 2011
 20 S1 p. S66-
1 p.
 artikel
200 P276 Simultaneous study of gemcitabine–docetaxel combination adjuvant treatment, as well as biological targeted treatment: the SUCCESS B Trial Andergassen, U.
 2011
 20 S1 p. S66-
1 p.
 artikel
201 P151 Smoking habits and breast cancer: Substantially reduced risk for smokers observed in screening trials using X ray diffraction of hair by synchrotron Polizzi, S.
 2011
 20 S1 p. S30-
1 p.
 artikel
202 P166 Stereotactic vacuum assisted breast biopsy system (BLES) utilizing radiofrequency: A matter of time Papapanagiotou, I.K.
 2011
 20 S1 p. S34-
1 p.
 artikel
203 P342 Stigma attached to breast cancer in North Africa and the Middle East, how to erase it? Kaadan, M.I.
 2011
 20 S1 p. S83-
1 p.
 artikel
204 P132 Subtoxic concentrations of paclitaxel increased the percent of Her-2 positive breast cancer cells Neskovic-Konstantinovic, Z.B.
 2011
 20 S1 p. S25-
1 p.
 artikel
205 P256 TARGIT-E(lderly) prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer Neumaier, C.
 2011
 20 S1 p. S61-
1 p.
 artikel
206 P259 TARGIT modulates miRNAs expression to control growth factors production in breast tissue Belletti, B.
 2011
 20 S1 p. S62-
1 p.
 artikel
207 P168 3 Tesla MRI is more useful for the evaluation of tumor extent of breast cancer: a comparative study with conventional 1.5 Tesla MRI Tanaka, H.
 2011
 20 S1 p. S35-
1 p.
 artikel
208 P114 The anti-neoplastic ErbB2-antibody 2C4 produces left ventricular dysfunction in murine hearts Tocchetti, C.G.
 2011
 20 S1 p. S20-
1 p.
 artikel
209 P121 The anti proliferative effect of Aloin and Aloe emodin on MCF-7 and MDA-MB-231 breast cancer cells Daud, M.M.
 2011
 20 S1 p. S22-
1 p.
 artikel
210 P348 The beliefs, knowledge, understanding and attitudes towards breast cancer amongst rural women in northern Nigeria Odiase, E.O.
 2011
 20 S1 p. S85-
1 p.
 artikel
211 P113 The biology and prognosis of breast cancer in Japanese patients under 50 years of age Nishimura, R.
 2011
 20 S1 p. S20-
1 p.
 artikel
212 P139 The clinical features and prognosis of tubular breast cancer Izquierdo, M.
 2011
 20 S1 p. S27-
1 p.
 artikel
213 P102 The clinical features and prognosis of tubular breast cancer Izquierdo, M.
 2011
 20 S1 p. S17-
1 p.
 artikel
214 P253 The consequences of shoulder mobility in early breast cancer patients with sentinel lymph node biopsy or axillary lymph node dissection Utsumi, T.
 2011
 20 S1 p. S60-S61
2 p.
 artikel
215 P339 The correlation of anxiety and depression levels with response to neo-adjuvant chemotherapy in patients with breast cancer – A prospective study Chintamani,
 2011
 20 S1 p. S82-S83
2 p.
 artikel
216 P293 The effect of zoledronic acid on bone mineral density and bone turnover in patients with early breast cancer on the AZURE trial Shankland, C.
 2011
 20 S1 p. S71-
1 p.
 artikel
217 P287 The effects of toremifene (TOR) and letrozole (LET) on serum lipids and bone metabolism in postmenopausal patients with estrogen receptor (ER) positive breast cancer – MULTI03 study interim report Doihara, H.
 2011
 20 S1 p. S69-
1 p.
 artikel
218 P205 The 70-gene expression profile, Mammaprint, for breast cancer patients in mainly European hospitals Zanconati, F.
 2011
 20 S1 p. S45-
1 p.
 artikel
219 P199 The 70-gene Mammaprint signature is an independent prognostic factor for elderly women with hormone receptor-positive, HER2-negative breast cancer Hartmann, S.
 2011
 20 S1 p. S43-S44
2 p.
 artikel
220 P220 The hybrid breast reconstruction – Use of autologous fat transfer to increase autologous tissue to implant ratio in oncoplastic breast reconstruction Young, A. Ott
 2011
 20 S1 p. S52-
1 p.
 artikel
221 P171 The impact of preoperative real-time virtual sonography (RVS) on breast-conserving therapy of breast cancer Yoshida, M.
 2011
 20 S1 p. S36-
1 p.
 artikel
222 P155 The incidence of third primary cancers in bilateral breast cancer patients Nowicka, E.
 2011
 20 S1 p. S31-
1 p.
 artikel
223 P282 The menopausal status of young Chinese women with early stage breast cancer after adjuvant chemotherapy Yeo, W.
 2011
 20 S1 p. S68-
1 p.
 artikel
224 P189 The methylation status of estrogen receptor-α negative [(ERα(−)] in correlation with the methylation status of SOCS1 gene in primary breast carcinoma (BC) Desiris, K.
 2011
 20 S1 p. S41-
1 p.
 artikel
225 P173 The preoperative MRI is useful for planning personalized local treatment in early breast cancer patients without increasing unnecessary extensive surgery Bando, H.
 2011
 20 S1 p. S36-
1 p.
 artikel
226 P147 The prevalence of ovarian cancer in Korean women at high risk of hereditary breast-ovarian cancer syndrome Lee, J.
 2011
 20 S1 p. S29-
1 p.
 artikel
227 P177 The prognostic significance of Ki-67 expression in patients with early invasive breast cancer Utsumi, T.
 2011
 20 S1 p. S37-
1 p.
 artikel
228 P158 The role of HPV in breast, ovarian and endometrial cancer Antonova, I.
 2011
 20 S1 p. S32-
1 p.
 artikel
229 P234 The role of pre-operative CT staging in predicting the sentinel lymph node status Khawaja, S.
 2011
 20 S1 p. S55-
1 p.
 artikel
230 P232 The role of preoperative MRI in influencing the surgical decision making, a retrospective look at the experience of a large academic hospital in the face of a rising mastectomy rates Ali, H.
 2011
 20 S1 p. S55-
1 p.
 artikel
231 P249 The Sentinella® experience – a new tool for sentinel node biopsy in breast cancer Ghosh, D.B.
 2011
 20 S1 p. S59-S60
2 p.
 artikel
232 P111 The Susan G. Komen for the Cure® Tissue Bank at the IU Simon Cancer Center: How normal breast tissue can facilitate breast cancer research Clare, S.E.
 2011
 20 S1 p. S19-
1 p.
 artikel
233 P236 3T-MRI can predict the metastasis of sentinel node detected by 3D-CT mammary lymphography Yamashita, K.
 2011
 20 S1 p. S56-
1 p.
 artikel
234 P230 Topography of lymphatics of the arm in axillary region – functional lymphatic anatomy for axilla surgery in breast cancer patient Pavlista, D.
 2011
 20 S1 p. S54-
1 p.
 artikel
235 P128 Transformation of breast fibroadenoma to ductal carcinoma in situ and malignant breast tumour Chow, L.W.-C.
 2011
 20 S1 p. S24-
1 p.
 artikel
236 P136 Triple negative breast cancer: Experience of the Clinic of Oncology, Clinical Center Nis during a 3-year period (2007 –2009) Veselinovic, S.
 2011
 20 S1 p. S26-
1 p.
 artikel
237 P137 Triple negative breast cancer in population of eastern Switzerland: Clinical features and outcome Ess, S.
 2011
 20 S1 p. S26-
1 p.
 artikel
238 P311 Tumor-infiltrating lymphocytes are an important pathological predictor for neoadjuvant chemotherapy in patients with breast cancer Yamaguchi, R.
 2011
 20 S1 p. S76-
1 p.
 artikel
239 P269 Ultrasound myocardial tissue characterization by integrated backscatter detects preclinical myocardial damage in patients with breast cancer treated with postoperative adjuvant radiotherapy Zhang, Y.
 2011
 20 S1 p. S64-S65
2 p.
 artikel
240 P345 Updated guidance for the prevention of aromatase inhibitor (AI)-associated bone loss (AIBL) in early breast cancer (EBC) Hadji, P.
 2011
 20 S1 p. S84-
1 p.
 artikel
241 P107 Vasohibin as a potential negative feedback regulator and a newly identified biomarker of angiogenesis in human breast carcinoma Tamaki, K.
 2011
 20 S1 p. S18-
1 p.
 artikel
242 P294 What is the key issue to evaluate adherence to endocrine treatment in breast cancer patients? Methodological results of a prospective study: Patient-reported outcomes in breast cancer patients undergoing endocrine therapy (PRO-BETh) Achleitner, R.
 2011
 20 S1 p. S71-S72
2 p.
 artikel
243 P227 When can a second conservative approach be considered for ipsilateral breast tumor recurrence? Del Castillo, A.
 2011
 20 S1 p. S54-
1 p.
 artikel
244 S30 Abbreviated course of radiotherapy (RT) for breast cancer Harris, J.
 2011
 20 S1 p. S11-S12
2 p.
 artikel
245 S39 Adjuvant systemic therapy for the older woman with breast cancer Albain, K.
 2011
 20 S1 p. S15-
1 p.
 artikel
246 S40 Adjuvant therapies for special types of breast cancer Colleoni, M.
 2011
 20 S1 p. S15-S16
2 p.
 artikel
247 S38 Adjuvant therapies for the very young Partridge, A.
 2011
 20 S1 p. S14-S15
2 p.
 artikel
248 S14 Antiangiogenic therapy for breast cancer: What now? Kerbel, R.
 2011
 20 S1 p. S5-
1 p.
 artikel
249 S02 Beyond trastuzumab: new anti-HER2 agents Piccart, M.
 2011
 20 S1 p. S1-S2
2 p.
 artikel
250 S18 Breast cancer and microRNAs: Therapeutic impact Iorio, M.
 2011
 20 S1 p. S6-
1 p.
 artikel
251 S12 Breast cancer, stroma and metastases Gomis, R.
 2011
 20 S1 p. S4-S5
2 p.
 artikel
252 S17 Breast stem and progenitor cells in cancer – Therapeutic implications Lindeman, G.
 2011
 20 S1 p. S6-
1 p.
 artikel
253 S16 Breast stem cells and hormonal mechanisms in carcinogenesis Brisken, C.
 2011
 20 S1 p. S6-
1 p.
 artikel
254 S20 Changing the guidelines for breast cancer screening: modeling mammography benefits and harms Mandelblatt, J.
 2011
 20 S1 p. S7-S8
2 p.
 artikel
255 S37 Characteristics of breast cancer patients unlikely to benefit from adjuvant therapy Ejlertsen, B.
 2011
 20 S1 p. S14-
1 p.
 artikel
256 Scientific program – Friday, 18 March 2011 2011
 20 S1 p. x-
1 p.
 artikel
257 Scientific program – Overview 2011
 20 S1 p. vi-vii
nvt p.
 artikel
258 Scientific program – Saturday, 19 March 2011 2011
 20 S1 p. xi-
1 p.
 artikel
259 Scientific program – Thursday, 17 March 2011 2011
 20 S1 p. ix-
1 p.
 artikel
260 Scientific program – Wednesday, 16 March 2011 2011
 20 S1 p. viii-
1 p.
 artikel
261 S13 Cytotoxic drugs: The endocrine part of the story Dowsett, M.
 2011
 20 S1 p. S5-
1 p.
 artikel
262 S42 Disease related indicators for a proper choice of adjuvant treatments Hayes, D.
 2011
 20 S1 p. S16-
1 p.
 artikel
263 S21 Evolution of breast imaging: Beyond mammography Kuhl, C.
 2011
 20 S1 p. S8-
1 p.
 artikel
264 S25 Immediate breast reconstruction after mastectomy Veronesi, P.
 2011
 20 S1 p. S10-
1 p.
 artikel
265 S19 Immunity and autoimmunity: Revising the concepts of response to cancer Curigliano, G.
 2011
 20 S1 p. S7-
1 p.
 artikel
266 S32 Integrated therapies for the next decade: A vision for the future Veronesi, U.
 2011
 20 S1 p. S12-
1 p.
 artikel
267 S29 Intraoperative radiation therapy: Is it a standard now? Orecchia, R.
 2011
 20 S1 p. S11-
1 p.
 artikel
268 S03 Is caring for the bone also fighting the breast cancer? Coleman, R.
 2011
 20 S1 p. S2-
1 p.
 artikel
269 S23 Is gene array testing to be considered routine now? Paik, S.
 2011
 20 S1 p. S9-
1 p.
 artikel
270 S41 Is there a case for anti-HER2 treatment without chemotherapy? Smith, I.
 2011
 20 S1 p. S16-
1 p.
 artikel
271 S36 Lessons from the neoadjuvant setting on how best to choose adjuvant therapies von Minckwit, G.
 2011
 20 S1 p. S14-
1 p.
 artikel
272 S28 Local therapy for breast cancer in malignant lymphoma survivors Intra, M.
 2011
 20 S1 p. S10-S11
2 p.
 artikel
273 S04 Molecular classification of breast cancer and its emerging clinical relevance Perou, C.
 2011
 20 S1 p. S2-S3
2 p.
 artikel
274 S05 Molecular mechanisms which predict response to chemotherapy Sotiriou, C.
 2011
 20 S1 p. S3-
1 p.
 artikel
275 S10 Obesity and insulin resistance – Chemoprevention strategies with a focus on metformin Goodwin, P.
 2011
 20 S1 p. S4-
1 p.
 artikel
276 S24 Oncoplastic surgery: Overview and recommendations for training Urban, C.
 2011
 20 S1 p. S9-S10
2 p.
 artikel
277 S07 Overcoming resistance to endocrine therapies: Multiple interventions to reach the goal Schiff, R.
 2011
 20 S1 p. S4-
1 p.
 artikel
278 S01 PARP inhibitors – walking them through to adjuvant Tutt, A.
 2011
 20 S1 p. S1-
1 p.
 artikel
279 S22 Pathological work up of the primary tumor: Getting the proper information out of it Viale, G.
 2011
 20 S1 p. S8-S9
2 p.
 artikel
280 S34 Patients with anti-HER2 responsive disease: Definition and adjuvant therapies Burstein, H.
 2011
 20 S1 p. S12-S13
2 p.
 artikel
281 S35 Patients with triple negative breast cancer Di Leo, A.
 2011
 20 S1 p. S13-S14
2 p.
 artikel
282 S27 Positive axillary sentinel lymph node: Is axillary dissection always necessary? Galimberti, V.
 2011
 20 S1 p. S10-
1 p.
 artikel
283 S26 Prophylactic mastectomy of the contralateral breast Morrow, M.
 2011
 20 S1 p. S10-
1 p.
 artikel
284 S15 Response to antiangiogesis: An ever changing feature Bertolini, F.
 2011
 20 S1 p. S5-
1 p.
 artikel
285 S31 Treatment of local reappearance of breast cancer Vicini, F.A.
 2011
 20 S1 p. S12-
1 p.
 artikel
                             285 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland